D-0470-2025 Class III Ongoing
FDA drug recall D-0470-2025 was initiated by Macleods Pharmaceuticals Ltd on May 29, 2025 and is designated Class III. Reason for recall: Presence of a foreign substance: black hair found embedded in tablet. The recall status is ongoing. Affected quantity: 1,344- 1000 count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 18, 2025
- Initiation Date
- May 29, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,344- 1000 count bottles
Product description
Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540. Manufactured by: Macleods Pharmaceuticals Ltd. Sarigam, Valsad, Gujarat, India, NDC 33342-398-44.
Reason for recall
Presence of a foreign substance: black hair found embedded in tablet.
Distribution pattern
Nationwide in the USA
Code information
Lot #: MLF2401A, Exp 01/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0470-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026